Travere Therapeutics (TVTX) Enterprise Value: 4.873B

Travere Therapeutics, Inc. (TVTX)

50.39 -0.18 (-0.36%) USD | NASDAQ | Oct 30, 16:00

50.38 -0.01 (-0.02%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2008. Start Trial.

Date	Value
October 30, 2026	4.873B
October 29, 2026	4.890B
October 28, 2026	4.916B
October 27, 2026	4.919B
October 26, 2026	4.834B
October 23, 2026	4.844B
October 22, 2026	5.065B
October 21, 2026	5.079B
October 20, 2026	5.053B
October 19, 2026	4.883B
October 16, 2026	4.799B
October 15, 2026	5.099B
October 14, 2026	5.144B
October 13, 2026	5.006B
October 12, 2026	5.027B
October 09, 2026	5.037B
October 08, 2026	5.029B
October 07, 2026	5.160B
October 06, 2026	5.400B
October 05, 2026	5.559B
October 02, 2026	5.489B
October 01, 2026	5.482B
September 30, 2026	5.673B
September 29, 2026	5.777B
September 28, 2026	5.926B

Date	Value
September 25, 2026	5.725B
September 24, 2026	5.837B
September 23, 2026	5.762B
September 22, 2026	5.805B
September 21, 2026	6.048B
September 18, 2026	6.038B
September 17, 2026	6.225B
September 16, 2026	6.106B
September 15, 2026	6.015B
September 14, 2026	6.323B
September 11, 2026	6.359B
September 10, 2026	6.485B
September 09, 2026	6.364B
September 08, 2026	6.350B
September 04, 2026	6.275B
September 03, 2026	6.394B
September 02, 2026	6.459B
September 01, 2026	6.316B
August 31, 2026	6.370B
August 28, 2026	6.312B
August 27, 2026	6.486B
August 26, 2026	6.449B
August 25, 2026	6.438B
August 24, 2026	6.270B
August 21, 2026	6.316B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks